Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-18

FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for butorphanol tartrate submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to the generic product's a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butorphanol Tartrate (Butorphanol tartrate)

Snippet

SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)